Dimenhydrinate 50 MG Oral Tablet — RxCUI 198603
RxNorm drug concept · Semantic clinical drug
RxCUI 198603
Semantic clinical drug · SCD
● Current RxNorm concept 22 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198603
Official nameDimenhydrinate 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped22
Package NDCs mapped31
Reported Medicaid activity (SDUD)2,199 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dimenhydrinate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It prevents and treats the nausea, vomiting and dizziness of motion sickness. You'll see it in products like Dramamine and Gravol, and as an injection used in medical settings.
- To prevent motion sickness, take your first dose about 30 to 60 minutes before you start traveling. After that, follow the repeat timing and daily limit on your product's label. Ch...
- Quite possibly. Drowsiness is the most common side effect. Be careful driving or using machinery, and skip alcohol.
- Tell me what else you take. Sedatives, tranquilizers and other sedating drugs can add to drowsiness. It can also hide warning signs of ear damage from certain antibiotics.
🕸️ Concept Web — How Dimenhydrinate 50 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dimenhydrinate 50 MG Oral Tablet
RxCUI 198603 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dimenhydrinate
3444IN
-
Dimenhydrinate
-
Brand names 5
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Dramamine
151666BN -
Driminate
216742BN -
Gravol
2594763BN -
TripTone
220486BN -
Wal-Dram
1086951BN
-
Dramamine
-
Dose forms 21
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dimenhydrinate Oral Tablet
371866SCDF -
Dimenhydrinate Oral Product
1151896SCDG -
Dimenhydrinate Pill
1151897SCDG -
Dimenhydrinate Oral Tablet [Dramamine]
367709SBDF -
Dimenhydrinate Oral Tablet [Driminate]
367708SBDF -
Dimenhydrinate Oral Tablet [Gravol]
2594773SBDF -
Dimenhydrinate Oral Tablet [TripTone]
367703SBDF -
Dimenhydrinate Oral Tablet [Wal-Dram]
1086953SBDF - +13 more in this family
-
Dimenhydrinate Oral Tablet
-
Clinical & branded drugs 11
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dimenhydrinate 50 MG
315830SCDC -
Dimenhydrinate 50 MG Oral Tablet [Dramamine]
201716SBD -
Dimenhydrinate 50 MG Oral Tablet [Driminate]
211482SBD -
Dimenhydrinate 50 MG Oral Tablet [Gravol]
2594774SBD -
Dimenhydrinate 50 MG Oral Tablet [TripTone]
211486SBD -
Dimenhydrinate 50 MG Oral Tablet [Wal-Dram]
1086954SBD -
Dimenhydrinate 50 MG [Dramamine]
565985SBDC -
Dimenhydrinate 50 MG [Driminate]
571867SBDC - +3 more in this family
-
Dimenhydrinate 50 MG
Showing up to 8 concepts per family — 22 of 38 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dimenhydrinate 50 MG
SCDC · 315830 -
Dimenhydrinate Oral Tablet
SCDF · 371866 -
Dimenhydrinate Oral Product
SCDG · 1151896 -
Dimenhydrinate Pill
SCDG · 1151897
Brand-Name Concepts
-
Dimenhydrinate 50 MG Oral Tablet [Dramamine]
SBD · 201716 -
Dimenhydrinate 50 MG Oral Tablet [Driminate]
SBD · 211482 -
Dimenhydrinate 50 MG Oral Tablet [Gravol]
SBD · 2594774 -
Dimenhydrinate 50 MG Oral Tablet [TripTone]
SBD · 211486 -
Dimenhydrinate 50 MG Oral Tablet [Wal-Dram]
SBD · 1086954 -
Dimenhydrinate 50 MG [Dramamine]
SBDC · 565985 -
Dimenhydrinate 50 MG [Driminate]
SBDC · 571867 -
Dimenhydrinate 50 MG [Gravol]
SBDC · 2594769 -
Dimenhydrinate 50 MG [TripTone]
SBDC · 571871 -
Dimenhydrinate 50 MG [Wal-Dram]
SBDC · 1086952
📦 FDA Products & Package NDCs
22 products · 31 package NDCs
31 package NDCs map to RxCUI 198603 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-1980-08 | 4 BLISTER PACK in 1 CARTON (0363-1980-08) / 6 TABLET in 1 B... | Motion Sickness Relief | Walgreen Company | 2021-10-22 |
| 00904-2051-12 | 2 BLISTER PACK in 1 CARTON (0904-2051-12) / 6 TABLET in 1 B... | Driminate | Major Pharmaceuticals | 1992-12-01 |
| 00904-2051-59 | 1 BOTTLE, PLASTIC in 1 CARTON (0904-2051-59) / 100 TABLET i... | Driminate | Major Pharmaceuticals | 1992-12-01 |
| 00904-6772-12 | 1 BLISTER PACK in 1 CARTON (0904-6772-12) / 12 TABLET in 1... | Dimenhydrinate | Major Pharmaceuticals | 2019-02-14 |
| 10237-0941-10 | 1 BLISTER PACK in 1 CARTON (10237-941-10) / 10 TABLET, COAT... | Gravol | Church & Dwight Co., Inc. | 2022-03-02 |
| 10237-0941-30 | 3 BLISTER PACK in 1 CARTON (10237-941-30) / 10 TABLET, COAT... | Gravol | Church & Dwight Co., Inc. | 2024-05-15 |
| 11673-0198-02 | 2 BLISTER PACK in 1 CARTON (11673-198-02) / 6 TABLET in 1 B... | Motion Sickness | Target Corporation | 1992-12-01 |
| 11673-0198-08 | 4 BLISTER PACK in 1 CARTON (11673-198-08) / 6 TABLET in 1 B... | Motion Sickness | Target Corporation | 1992-12-01 |
| 11673-0354-24 | 4 BLISTER PACK in 1 CARTON (11673-354-24) / 6 TABLET in 1 B... | Motion Sickness Relief | TARGET CORPORATION | 2025-03-31 |
| 11822-0198-02 | 2 BLISTER PACK in 1 CARTON (11822-0198-2) / 6 TABLET in 1 B... | Motion Sickness Relief | Rite Aid Corporation | 1992-12-01 |
| 11822-0198-07 | 6 BLISTER PACK in 1 CARTON (11822-0198-7) / 6 TABLET in 1 B... | Motion Sickness Relief | Rite Aid Corporation | 1992-12-01 |
| 36800-0930-12 | 2 BLISTER PACK in 1 CARTON (36800-930-12) / 6 TABLET in 1 B... | Motion Sickness Relief | Topco Associates, LLC | 1992-12-01 |
| 46122-0536-53 | 2 BLISTER PACK in 1 CARTON (46122-536-53) / 6 TABLET in 1 B... | Motion Sickness Relief | Amerisource Bergen | 1992-12-01 |
| 49035-0981-12 | 100 TABLET in 1 BOTTLE, PLASTIC (49035-981-12) | Motion Sickness Relief | Wal-Mart Stores Inc | 1992-12-01 |
| 50804-0198-02 | 2 BLISTER PACK in 1 CARTON (50804-198-02) / 6 TABLET in 1 B... | Motion Sickness | Geiss, Destin & Dunn Inc. | 2020-04-07 |
| 50844-0199-02 | 2 BLISTER PACK in 1 CARTON (50844-199-02) / 6 TABLET in 1 B... | Motion Sickness Relief | L.N.K. International, Inc. | 1992-12-01 |
| 59779-0198-02 | 2 BLISTER PACK in 1 CARTON (59779-198-02) / 6 TABLET in 1 B... | Motion Sickness | CVS Pharmacy | 1992-12-01 |
| 59779-0198-07 | 6 BLISTER PACK in 1 CARTON (59779-198-07) / 6 TABLET in 1 B... | Motion Sickness | CVS Pharmacy | 1992-12-01 |
| 63029-0901-01 | 3 BLISTER PACK in 1 BOX (63029-901-01) / 12 TABLET in 1 BLI... | Dramamine Original Formula | Medtech Products Inc. | 2012-01-15 |
| 63029-0901-02 | 1 BOTTLE in 1 BOX (63029-901-02) / 12 TABLET in 1 BOTTLE | Dramamine Original Formula | Medtech Products Inc. | 2012-01-15 |
| 63029-0901-03 | 1 POUCH in 1 CARTON (63029-901-03) / 2 TABLET in 1 POUCH | Dramamine Original Formula | Medtech Products Inc. | 2012-01-15 |
| 63941-0198-02 | 2 BLISTER PACK in 1 CARTON (63941-198-02) / 6 TABLET in 1 B... | Motion Sickness Relief | Valu Merchandisers Company | 2019-02-15 |
| 67091-0118-12 | 2 BLISTER PACK in 1 CARTON (67091-118-12) / 6 TABLET in 1 B... | Motion Sickness Relief | WinCo Foods, LLC | 1992-12-01 |
| 69168-0408-86 | 1 BLISTER PACK in 1 CARTON (69168-408-86) / 12 TABLET in 1... | Motion Sickness Relief | Allegiant Health | 2012-01-15 |
| 69842-0206-12 | 1 BLISTER PACK in 1 CARTON (69842-206-12) / 12 TABLET in 1... | Dimenhydrinate | CVS Pharmacy, Inc. | 2018-07-03 |
| 69842-0206-36 | 3 BLISTER PACK in 1 CARTON (69842-206-36) / 12 TABLET in 1... | Dimenhydrinate | CVS Pharmacy, Inc. | 2018-07-03 |
| 70000-0404-01 | 1 BLISTER PACK in 1 CARTON (70000-0404-1) / 12 TABLET in 1... | Dimenhydrinate | LEADER/ Cardinal Health 110, Inc. | 2019-01-04 |
| 70000-0749-01 | 2 BLISTER PACK in 1 CARTON (70000-0749-1) / 6 TABLET in 1 B... | Motion Sickness Relief | Cardinal Health 110, LLC. DBA Leader | 2025-12-05 |
| 70677-1087-01 | 2 BLISTER PACK in 1 CARTON (70677-1087-1) / 6 TABLET in 1 B... | Motion Sickness | Strategic Sourcing Services LLC | 2023-05-04 |
| 83324-0032-12 | 2 BLISTER PACK in 1 CARTON (83324-032-12) / 6 TABLET in 1 B... | Motion Sickness Relief | Chain Drug Marketing Association, Inc. | 2024-04-04 |
| 83324-0032-24 | 4 BLISTER PACK in 1 CARTON (83324-032-24) / 6 TABLET in 1 B... | Motion Sickness Relief | Chain Drug Marketing Association, Inc. | 2024-04-04 |
Observed labelers:
Major Pharmaceuticals (3) ·
Medtech Products Inc. (3) ·
Target Corporation (3) ·
Chain Drug Marketing Association, Inc. (2) ·
Church & Dwight Co., Inc. (2) ·
CVS Pharmacy (2)
· +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.